Certified by Founder Lodge 
                                        
                                        5AM Ventures
 
                                                 United States  -  San Francisco, California 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $100,000,000
                                            16 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies.  Within
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Karius | 
                                                            May, 03 ,2024 | Series C | $100,000,000 | 
   Karius | 
                                                            May, 03 ,2024 | Series C | $100,000,000 | 
   TMRW Life Sciences | 
                                                            July, 25 ,2024 | Series D | $28,000,000 | 
   CAMP4 Therapeutics | 
                                                            July, 20 ,2022 | Series B | $100,000,000 | 
   Renasant Bio | 
                                                            July, 11 ,2025 | Seed | $54,500,000 | 
   Ensoma | 
                                                            February, 06 ,2023 | Series B | $85,000,000 | 
   Fellow | 
                                                            July, 16 ,2025 | Series B | $24,000,000 | 
   TMRW Life Sciences | 
                                                            July, 25 ,2024 | Series D | $28,000,000 | 
   MapLight Therapeutics, Inc. | 
                                                            October, 31 ,2023 | Series C | $225,000,000 | 
   Renasant Bio | 
                                                            July, 11 ,2025 | Seed | $54,500,000 | 
   Radionetics Oncology | 
                                                            January, 04 ,2024 | Series A | $52,500,000 | 
   Latigo Biotherapeutics, Inc. | 
                                                            February, 15 ,2024 | Series A | $135,000,000 | 
   Karius | 
                                                            May, 03 ,2024 | Series C | $100,000,000 | 
   TMRW Life Sciences | 
                                                            July, 25 ,2024 | Series D | $28,000,000 | 
   Renasant Bio | 
                                                            July, 11 ,2025 | Seed | $54,500,000 | 
   Fellow | 
                                                            July, 16 ,2025 | Series B | $24,000,000 | 
                                                
  Karius
  TMRW Life Sciences
  CAMP4 Therapeutics
  Renasant Bio
  Ensoma
  Fellow
  MapLight Therapeutics, Inc.
  Radionetics Oncology
  Latigo Biotherapeutics, Inc.
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)